Dr Joanna Achinger-Kawecka
Joanna completed her PhD on the identification of microRNAs for the prediction of breast cancer treatment outcome at the Dr. Margarete-Fischer-Bosch-Institute of Clinical Pharmacology (IKP) in Stuttgart, Germany in late 2013 and then moved to Australia to join the Cancer Epigenetics Research group at the Garvan Institute.
In the NewsA 3D view of the cancer genome - Jun 06, 2016
2016 recipients of the Heliflite Young Explorer and CHAMP Young Pioneer Awards and the Palmer Innovation Prize announced - May 05, 2016
Awards and Honours
2011 – MSc (Biotechnology), Warsaw University of Life Sciences - Poland
Reiner Hoppe*, Joanna Achinger-Kawecka*, Stefan Winter, Peter Fritz, Wing-Yee Lo, Werner Schroth, Hiltrud Brauch. Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment. European Journal of Cancer, 2013, doi:10.1016/j.ejca.2013.07.145 *Equal first authors
Taberlay PC*, Achinger-Kawecka J*, Lun AT, Buske FA, Sabir K, Gould CM, Zotenko E, Bert SA, Giles KA, Bauer DC, Smyth GK, Stirzaker C, O'Donoghue SI, Clark S. Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations. Genome Research 2016, Epub ahead of print *Equal first authors